Short description
Cyterix Pharmaceuticals is a cancer therapeutics company developing small molecule prodrugs.
Description
Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The company's approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of anticancer prodrugs that are selectively activated by extra-hepatic cytochrome P450 enzymes that are greatly over-expressed in a broad range of solid tumor and hematologic cancers, but not in normal tissues.
Total funding
$$43214321
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2010
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Uh Ohhhh
Sign in for full access
Founders
Steven Everett